Tezepelumab for asthma with current or previous smoking habit: Case series
Tezepelumab effectively treated severe asthma in a current smoker and a former smoker, suggesting that thymic stromal lymphopoietin is involved in the pathogenesis of severe asthma in these patients. Tezepelumab may additionally be used for severe asthma in current and former smokers.
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2025-05-01
|
| Edice: | Journal of Allergy and Clinical Immunology: Global |
| Témata: | |
| On-line přístup: | http://www.sciencedirect.com/science/article/pii/S2772829325000219 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|